Why Ampio Pharmaceuticals Stock Is Rising Today

Ampio Pharmaceuticals Inc AMPE shares are trading significantly higher Thursday following bullish analyst coverage.

Alliance Global Partners analyst James Molloy initiated coverage on Ampio Pharmaceuticals with a Buy rating and announced a $4.50 price target, which is well above current levels.

The company is set to report its fourth-quarter financial results after the market closes on March 29.

Ampio Pharmaceuticals is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions.

See Also: Why Nikola Shares Are Soaring Today

AMPE Price Action: Ampio has traded between 39 cents and $2 over a 52-week period.

The stock was up 53.7% at 66 cents at time of publication.

Photo: Parentingupstream from Pixabay.